Literature DB >> 29223988

Prevalence of Physical Problems Detected by the Distress Thermometer and Problem List in Patients With Myeloproliferative Disorders.

Daniel C McFarland, Kelly M Shaffer, Heather Polizzi, John Mascarenhas, Marina Kremyanskaya, Jimmie Holland, Ronald Hoffman.   

Abstract

Background: Patients with myeloproliferative neoplasms (MPNs) can have a severe physical symptom burden over an extended disease trajectory that contributes to decreased quality of life. Few studies, however, have characterized which patients most frequently consider physical symptoms a problem. This study describes the physical symptoms of patients with MPNs and the relationship of these symptoms to patient characteristics.
Methods: Patients with MPNs (N=117) completed questionnaires in a dedicated academic medical center MPN clinic. Patients reported demographics (age, race/ethnicity, sex, marital status, employment status), disease characteristics (MPN type, time with MPN), and whether they were bothered by any of 22 variables in the "Physical Problems" list in the Distress Thermometer and Problem List (DT&PL).
Results: The median number of physical problems endorsed by patients was 2 (median, 2.26; SD, 3.18), with a range from 0 to 20. Two-fifths endorsed no physical problems, one-fifth endorsed 1 problem, and two-fifths endorsed ≥2 problems, with fatigue (35.5%), sleep (27.1%), pain (21.5%), dry skin/pruritus (18.7%), and memory/concentration (16.8%) being the most commonly reported. Non-Caucasian participants reported more problems with sleep (P=.050), pain (P=.016), and tingling (P=.026). Patients with polycythemia vera (PV) reported more issues with tingling (P=.046) and sexual problems (P=.032). Conclusions: Patients with MPNs are more likely to report physical symptom bother than to report no bother with multiple physical problems on the DT&PL. Patients of minority race/ethnicity and those with PV, however, showed heightened prevalence of physical problems-characteristics which may be used to triage patients for more intensive symptom management.
Copyright © 2017 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2017        PMID: 29223988      PMCID: PMC5873606          DOI: 10.6004/jnccn.2017.7017

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  24 in total

1.  Use of the Functional Assessment of Cancer Therapy--anemia in persons with myeloproliferative neoplasm-associated myelofibrosis and anemia.

Authors:  Ayalew Tefferi; Stacie Hudgens; Ruben Mesa; Robert Peter Gale; Srdan Verstovsek; Francesco Passamonti; Francisco Cervantes; Candido Rivera; Tom Tencer; Zeba M Khan
Journal:  Clin Ther       Date:  2014-03-14       Impact factor: 3.393

Review 2.  Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force.

Authors:  William F Pirl; Jesse R Fann; Joseph A Greer; Ilana Braun; Teresa Deshields; Caryl Fulcher; Elizabeth Harvey; Jimmie Holland; Vicki Kennedy; Mark Lazenby; Lynne Wagner; Meghan Underhill; Deborah K Walker; James Zabora; Bradley Zebrack; Wayne A Bardwell
Journal:  Cancer       Date:  2014-05-02       Impact factor: 6.860

3.  The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.

Authors:  Robyn Scherber; Amylou C Dueck; Peter Johansson; Tiziano Barbui; Giovanni Barosi; Alessandro M Vannucchi; Francesco Passamonti; Bjorn Andreasson; Maria L Ferarri; Alessandro Rambaldi; Jan Samuelsson; Gunnar Birgegard; Ayalew Tefferi; Claire N Harrison; Deepti Radia; Ruben A Mesa
Journal:  Blood       Date:  2011-05-02       Impact factor: 22.113

4.  Regularity of daily life in relation to personality, age, gender, sleep quality and circadian rhythms.

Authors:  T H Monk; S R Petrie; A J Hayes; D J Kupfer
Journal:  J Sleep Res       Date:  1994-12       Impact factor: 3.981

5.  The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.

Authors:  Ruben A Mesa; Joyce Niblack; Martha Wadleigh; Srdan Verstovsek; John Camoriano; Sunni Barnes; Angelina D Tan; Pamela J Atherton; Jeff A Sloan; Ayalew Tefferi
Journal:  Cancer       Date:  2007-01-01       Impact factor: 6.860

Review 6.  Effect of age and race on quality of life in young breast cancer survivors.

Authors:  Phuong Khanh Morrow; Anita C Broxson; Mark F Munsell; Karen Basen-Enquist; Carol K Rosenblum; Leslie R Schover; Lynne H Nguyen; Limin Hsu; Lilibeth Castillo; Karin M Hahn; Jennifer K Litton; Danielle N Kwiatkowski; Gabriel N Hortobagyi
Journal:  Clin Breast Cancer       Date:  2013-10-25       Impact factor: 3.225

7.  Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.

Authors:  Carol Tishelman; Lena-Marie Petersson; Lesley F Degner; Mirjam A G Sprangers
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

8.  Psychological Symptoms Among Patients With BCR-ABL-Negative Myeloproliferative Neoplasms.

Authors:  Daniel C McFarland; Heather Polizzi; John Mascarenhas; Marina Kremyanskaya; Jimmie Holland; Ronald Hoffman
Journal:  J Natl Compr Canc Netw       Date:  2016-12       Impact factor: 11.908

9.  Burning feet in polycythemia vera - peripheral sensorimotor axonal neuropathy with erythromelalgia.

Authors:  Uwe Wollina
Journal:  Int J Gen Med       Date:  2015-02-02

10.  Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey.

Authors:  Ruben A Mesa; Carole B Miller; Maureen Thyne; James Mangan; Sara Goldberger; Salman Fazal; Xiaomei Ma; Wendy Wilson; Dilan C Paranagama; David G Dubinski; Ahmad Naim; Shreekant Parasuraman; John Boyle; John O Mascarenhas
Journal:  Cancer       Date:  2016-09-30       Impact factor: 6.860

View more
  3 in total

1.  Associations of Physical and Psychologic Symptom Burden in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Authors:  Daniel C McFarland; Kelly M Shaffer; Heather Polizzi; John Mascarenhas; Marina Kremyanskaya; Jimmie Holland; Ronald Hoffman
Journal:  Psychosomatics       Date:  2018-01-31       Impact factor: 2.386

2.  Physical problem list accompanying the distress thermometer: Its associations with psychological symptoms and survival in patients with metastatic lung cancer.

Authors:  Daniel C McFarland; Devika R Jutagir; Andrew Miller; Christian Nelson
Journal:  Psychooncology       Date:  2020-03-11       Impact factor: 3.894

Review 3.  The Critical Role of Inflammation in the Pathogenesis and Progression of Myeloid Malignancies.

Authors:  Brianna M Craver; Kenza El Alaoui; Robyn M Scherber; Angela G Fleischman
Journal:  Cancers (Basel)       Date:  2018-04-03       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.